Infectious Diseases Research Directory

David P. Calfee, MD, MS

Assistant Professor of Medicine and Public Health

Chief Hospital Epidemiologist (NewYork-Presbyterian Hospital/Weill Cornell Medical Center)


Tel: 212-746-1864

The major focus of my research activities has been the epidemiology and prevention of health care-associated infections, particularly those caused by multidrug-resistant organisms (MDRO).  Recent projects have included studies of methicillin-resistant S. aureus (MRSA) in patients with end-stage renal disease, Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae, influenza, vascular access-associated bloodstream infections in hemodialysis patients, and surgical site infections in liver transplant recipients.  The hospital’s Infection Prevention and Control Program provides a wide variety of opportunities in clinical research and quality improvement initiatives for residents with interests in infectious diseases, epidemiology, and patient safety.

Recent Residents and Fellows Mentored (at Mount Sinai): David Banach, Rebecca Bielang, Mahesh Swaminathan, Meena Rana


Daniel Fitzgerald, MD

Associate Professor of Medicine


Tel: 212-746-6320

Research areas of interest include HIV/AIDS prevention and therapeutic clinical trials, tuberculosis clinical trials, and evaluations of HIV and TB service programs in Haiti and Tanzania.

Recent Residents Mentored: Matt Simon, Sean Collins, Karl Bezak, Maryam Schafee

Marshall J. Glesby, MD, PhD

Associate Professor of Medicine


Tel: 212-746-7134

The major focus of my clinical research is the investigation of metabolic
complications in HIV-infected and HCV/HIV co-infected patients, including visceral fat accumulation and disordered glucose metabolism. Residents have participated in clinical epidemiological studies using data from the HIV clinic (the Center for Special Studies) and a multicenter cohort study of HIV-infected women.


Linnie M. Golightly, MD

Associate Professor of Clinical Medicine


Tel: 212-746-1601


Research projects that might be amenable to resident involvement include multiplex detection of pathogens and bioterror agents. Existing detection systems have a limited ability to simultaneously screen a single sample for multiple agents.  To meet this need, we are using the ligase detection reaction (LDR) combined with PCR and Universal Array detection. Multiplexed detection of food and waterborne pathogens will be validated using samples obtained from the NYPH/Weill Cornell as well as collaborators in Haiti and Ghana; multiplexed detection of bioterror agents will involve viral pathogens (Dengue, West Nile) obtained from the CDC, NYC Department of Health and sites of endemic disease.

Recent Resident Mentored: Magdalena Slosar


Roy M. (Trip) Gulick, MD, MPH

Professor of Medicine; Chief, Division of Infectious Diseases

(Assistant: Donna Reyes:
Tel: 212-746-6320

Current research interests include designing, conducting and analyzing clinical trials in HIV-infected subjects to assess antiretroviral drugs with novel mechanisms of action, refining antiretroviral therapy strategies, and testing immune-based therapies. Dr. Gulick is the Principal Investigator of the Cornell AIDS Clinical Trials Unit, sponsored by the NIH.

Kristen Marks, MD

Assistant Professor of Medicine


Tel: 212-746-6309

Working with our residents has been a gratifying experience. Research focus is on HIV and viral hepatitis coinfection liver disease primarily related to hepatitis B and C coinfection.  Clinical research aims to understand risk factors for disease progression and strategies to optimize treatment outcomes in coinfected patients.

Recent Residents Mentored: Frank Scott, Sameer Kadri 


Kyu Y. Rhee, MD, PhD

Assistant Professor of Medicine


Tel: 212-746-4547  Pager: 16690

I am delighted to sponsor any housestaff with an interest in the molecular epidemiology and mechanisms of antibiotic resistance in clinical pathogens. We have recently focused on vancomycin resistance in Staphylococcus aureus and Enterococcus faecium but are fundamentally driven by clinical cases and observations seen in this medical center. I am easy to reach by phone (x64547), email, or pager (16690), and would be more than delighted to have any member of the housestaff with an interest in ID come by.

Recent Resident Mentored: Anna Kaltsas (currently ID fellow at AECOM)


Kent A. Sepkowitz, MD (and Mini Kamboj, MD)

MSKCC, Hospital Infection Control


Tel: 212-639-2441

The Infection Control Program at MSKCC invites residents interested in hospital epidemiology. Previous projects involving NYPH-Cornell residents have included prevalence of HCV in Rogosin dialysis patients; risks for Clostridium difficile in MSKCC outpatients; seroconversion rates in health care workers vaccinated for varicella; control of influenza on a bone marrow transplant unit; and prevalence of markers for hepatitis B and C in Chinatown Health Clinic. Current NYPH-Cornell resident projects include clinical comparison of hypervirulent tcdc deletion C. difficile to standard C. difficile and CNS infection in cancer patients. Interested residents should contact Kent Septowitz.

Recent Residents Mentored: Peter Mead, Matt Simon


Mary Vogler, MD

Assistant Professor of Medicine


Tel: 212-746-7200

My areas of clinical research interest, in association with the AIDS Clinical Trials Group, are in HIV infection in women and perinatal HIV infection.

Recent Residents Mentored: Ritu Pati (currently ID fellow at Weill Cornell), Sabena Ramsetty (currently ID fellow at University of Virginia) 


Thomas J. Walsh, MD

Professor of Medicine

Director, Transplantation-Oncology Infectious Diseases Program


Tel: 212-746-6320

The mission of the Transplantation-Oncology Infectious Diseases Program is to develop new strategies for diagnosis, treatment and prevention of life-threatening infections in immunocompromised patients.  We accomplish this mission through translational laboratory and clinical research focusing on (1) antimicrobial pharmacology; (2) augmentation of innate host defenses; (3) molecular detection of emerging pathogens.  The advances achieved through laboratory investigations are translated through carefully designed clinical protocols in hematopoietic stem cell transplant recipients, solid organ transplant recipients and patients with hematological malignancies.


Timothy Wilkin, MD, MPH

Assistant Professor of Medicine


Tel: 212-746-7202

Research interests are in the epidemiology and treatment of human papillomavirus (HPV) related anal dysplasia in HIV-infected men and women. Ongoing and planned projects include determining the predictors of persistent anal infection with HPV, describing outcomes for patients treated for high grade anal intraepithelial neoplasia (HGAIN) and topical therapies for HGAIN.

For More Information

For additional information regarding the medical research track and a description of research projects pursued by our faculty, please refer to the following sites:

Research at Weill Cornell Medical College
Research at Memorial Sloan-Kettering Cancer Center
Research at the Hospital for Special Surgery
Research at The Rockefeller University

Top of page